Next-Generation Therapeutics- A huge success

November 18, 2022

News Details

The summit saw exciting talks and discussions by experts from different fields and backgrounds. They stressed the need for the industry and academia to come together on the same platform. Increased networking and collaboration can help deliver a market-vetted need statement, which academic researchers can follow to meet market needs. Such streamlined research will not only open up marketing opportunities for academic translational work but also lead to the indigenous development of therapeutics directly impacting developing economies such as India.

We had over 300 registrations and ~260 registered attendees consisting of faculty members, students, postdocs, industries, startups, clinicians, etc. We had participants from MP Biomedicals, HiMedia Labs Pvt. Ltd., AstraZeneca, Biocon Biologics, Dr. Reddy's Laboratories, LifeCell International Pvt Ltd, Indian Council of Medical Research, Ankur Capital, Senior advisor from the Office of the Principal Scientific Adviser to the Government of India, etc.

The meeting was followed by an interactive poster session, which exhibited the wide range of research work done in the therapeutics area by the WRCB faculty members. We also had a poster exclusively on the 'External Fundraising Support' service by WRCB. We received overwhelming feedback from many attendees. The event witnessed numerous networking, insightful talks, and open discussions on how industry and academia can jointly venture into the next-generation therapeutics domain.

We are grateful to all our sponsors MP Biomedicals, HiMedia Labs Pvt Ltd, SAN instruments, Institution of Eminence, and IIT Bombay. We thank all the participants for making this event a huge success.

Moments from the event

Let's get the word out about this!

Back to Top
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram